Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 8.58B | 8.43B | 5.16B | 12.56B | 10.73B | 3.99B |
Gross Profit | 2.79B | 2.78B | -2.21B | 6.43B | 6.07B | 865.02M |
EBITDA | 3.91B | 3.82B | -955.10M | 7.65B | 6.60B | 1.00B |
Net Income | 2.00B | 2.15B | -2.70B | 4.62B | 4.64B | 518.00M |
Balance Sheet | ||||||
Total Assets | 11.10B | 11.39B | 8.35B | 11.63B | 9.84B | 2.82B |
Cash, Cash Equivalents and Short-Term Investments | 1.77B | 2.12B | 1.80B | 3.26B | 3.69B | 629.39M |
Total Debt | 5.92B | 6.02B | 5.01B | 4.35B | 3.32B | 1.83B |
Total Liabilities | 7.20B | 7.35B | 5.89B | 5.73B | 5.24B | 2.55B |
Stockholders Equity | 3.90B | 4.04B | 2.45B | 5.89B | 4.59B | 267.27M |
Cash Flow | ||||||
Free Cash Flow | 3.72B | 3.54B | 904.30M | 5.76B | 4.97B | 838.10M |
Operating Cash Flow | 3.95B | 3.75B | 1.02B | 6.11B | 5.97B | 880.80M |
Investing Cash Flow | -363.80M | -223.20M | 1.78B | -1.65B | -3.34B | -35.20M |
Financing Cash Flow | -3.29B | -3.13B | -2.89B | -4.98B | -1.65B | -460.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | $1.46B | 5.12 | 14.61% | 3.76% | -7.24% | -16.39% | |
80 Outperform | $1.72B | 3.87 | 13.38% | 3.62% | 5.63% | -17.54% | |
74 Outperform | $2.23B | 18.45 | 5.11% | 4.05% | 2.95% | -61.74% | |
67 Neutral | $1.59B | 14.04 | 6.06% | 10.03% | -7.73% | -39.13% | |
63 Neutral | $10.84B | 15.28 | 7.40% | 1.99% | 2.87% | -14.59% | |
60 Neutral | $1.59B | 0.79 | 59.06% | 56.28% | 43.57% | ― | |
58 Neutral | $1.09B | 31.37 | 3.35% | 12.20% | 3.51% | -74.00% |